相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A multicentre analytical comparison study of inter-reader and inter-assay agreement of four programmed death-ligand 1 immunohistochemistry assays for scoring in triple-negative breast cancer
Aurelia Noske et al.
HISTOPATHOLOGY (2021)
Problematic breast tumors reassessed in light of novel molecular data
Fresia Pareja et al.
MODERN PATHOLOGY (2021)
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer
Francesco Schettini et al.
NPJ BREAST CANCER (2021)
Comparison of three FDA-approved diagnostic immunohistochemistry assays of PD-L1 in triple-negative breast carcinoma
Xiao Huang et al.
HUMAN PATHOLOGY (2021)
Quantitative assessment of PD-L1 as an analyte in immunohistochemistry diagnostic assays using a standardized cell line tissue microarray
Sandra Martinez-Morilla et al.
LABORATORY INVESTIGATION (2020)
Histologic spectrum of polymorphous adenocarcinoma of the salivary gland harbor genetic alterations affecting PRKD genes
Ana Paula Martins Sebastiao et al.
MODERN PATHOLOGY (2020)
Comprehensive Profiling of Poor-Risk Paired Primary and Recurrent Triple-Negative Breast Cancers Reveals Immune Phenotype Shifts
Katherine E. Hutchinson et al.
CLINICAL CANCER RESEARCH (2020)
Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment Approach
Yacine Bareche et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
Peter Schmid et al.
LANCET ONCOLOGY (2020)
Histologic Classification and Molecular Signature of Polymorphous Adenocarcinoma (PAC) and Cribriform Adenocarcinoma of Salivary Gland (CASG) An International Interobserver Study
Bin Xu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study
P. Schmid et al.
ANNALS OF ONCOLOGY (2020)
Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis
Laura M. Spring et al.
CLINICAL CANCER RESEARCH (2020)
Metastatic Breast Cancer: TIL it is Too Late
Peter Savas et al.
CLINICAL CANCER RESEARCH (2020)
Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study
Shanu Modi et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity
Fresia Pareja et al.
MODERN PATHOLOGY (2020)
The repertoire of mutational signatures in human cancer
Ludmil B. Alexandrov et al.
NATURE (2020)
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution
Saioa Lopez et al.
NATURE GENETICS (2020)
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
Shanu Modi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Pleomorphic adenomas and mucoepidermoid carcinomas of the breast are underpinned by fusion genes
Fresia Pareja et al.
NPJ BREAST CANCER (2020)
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
Zuzana Kos et al.
NPJ BREAST CANCER (2020)
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
Javier Cortes et al.
LANCET (2020)
A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies
Andrea Degasperi et al.
NATURE CANCER (2020)
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
Yi-Zhou Jiang et al.
CANCER CELL (2019)
Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers
Tina Gruosso et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
Ana C. Garrido-Castro et al.
CANCER DISCOVERY (2019)
Genomic characterization of metastatic breast cancers
Francois Bertucci et al.
NATURE (2019)
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research
C. Marchio et al.
ANNALS OF ONCOLOGY (2019)
Whole-exome sequencing and RNA sequencing analyses of acinic cell carcinomas of the breast
Francisco Beca et al.
HISTOPATHOLOGY (2019)
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis
Max D. Wellenstein et al.
NATURE (2019)
Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma
Allen S. Ho et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms
Ik Sun Kim et al.
NATURE CELL BIOLOGY (2019)
The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies
Lindsay Angus et al.
NATURE GENETICS (2019)
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
Johan Staaf et al.
NATURE MEDICINE (2019)
Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy
J. H. Park et al.
ANNALS OF ONCOLOGY (2019)
CRTC1-MAML2 fusion in mucoepidermoid carcinoma of the breast
Gregory R. Bean et al.
HISTOPATHOLOGY (2019)
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The Landscape of Somatic Genetic Alterations in Breast Cancers from CHEK2 Germline Mutation Carriers
Diana Mandelker et al.
JNCI CANCER SPECTRUM (2019)
MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene
Jisun Kim et al.
JOURNAL OF PATHOLOGY (2018)
Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis
Y. Bareche et al.
ANNALS OF ONCOLOGY (2018)
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
Ashton C. Berger et al.
CANCER CELL (2018)
The Tandem Duplicator Phenotype Is a Prevalent Genome-Wide Cancer Configuration Driven by Distinct Gene Mutations
Francesca Menghi et al.
CANCER CELL (2018)
Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing
Anna K. Casasent et al.
CELL (2018)
CD10+ GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
Shicheng Su et al.
CELL (2018)
The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers
Britta Weigelt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis
Willemijne A. M. E. Schrijver et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles
Simon Andreasen et al.
MODERN PATHOLOGY (2018)
Genome doubling shapes the evolution and prognosis of advanced cancers
Craig M. Bielski et al.
NATURE GENETICS (2018)
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
Andrew Tutt et al.
NATURE MEDICINE (2018)
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
A. Drilon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas
Felipe C. Geyer et al.
NATURE COMMUNICATIONS (2018)
The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers
Britta Weigelt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis
Willemijne A. M. E. Schrijver et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
The therapeutic significance of mutational signatures from DNA repair deficiency in cancer
Jennifer Ma et al.
NATURE COMMUNICATIONS (2018)
Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
Mihriban Karaayvaz et al.
NATURE COMMUNICATIONS (2018)
Classification of triple-negative breast cancers based on Immunogenomic profiling
Yin He et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano Cocco et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family
Felipe C. Geyer et al.
MODERN PATHOLOGY (2017)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer
Robert W. Mutter et al.
JOURNAL OF PATHOLOGY (2017)
Molecular alterations in triple-negative breast cancer-the road to new treatment strategies
Carsten Denkert et al.
LANCET (2017)
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
Paz Polak et al.
NATURE GENETICS (2017)
Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples
Luciano G. Martelotto et al.
NATURE MEDICINE (2017)
Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes
Nadeem Riaz et al.
NATURE COMMUNICATIONS (2017)
The Spectrum of Triple-Negative Breast Disease High- and Low-Grade Lesions
Felipe C. Geyer et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Genomic Evolution of Breast Cancer Metastasis and Relapse
Lucy R. Yates et al.
CANCER CELL (2017)
Genetic Heterogeneity in Therapy-Naive Synchronous Primary Breast Cancers and Their Metastases
Charlotte K. Y. Ng et al.
CLINICAL CANCER RESEARCH (2017)
Mutational Signatures in Breast Cancer: The Problem at the DNA Level
Serena Nik-Zainal et al.
CLINICAL CANCER RESEARCH (2017)
A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes
Saundra S. Buys et al.
CANCER (2017)
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
Peter Savas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Pure Apocrine Carcinomas Represent a Clinicopathologically Distinct Androgen Receptor-Positive Subset of Triple-Negative Breast Cancers
Anne M. Mills et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity
Sarah Chiang et al.
CANCER RESEARCH (2016)
Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations
Elena Guerini-Rocco et al.
JOURNAL OF PATHOLOGY (2016)
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer
Nicola Fusco et al.
MODERN PATHOLOGY (2016)
Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology
Paul S. Weisman et al.
MODERN PATHOLOGY (2016)
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
Carsten Denkert et al.
MODERN PATHOLOGY (2016)
Deletions linked to TP53 loss drive cancer through p53-independent mechanisms
Yu Liu et al.
NATURE (2016)
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal et al.
NATURE (2016)
Punctuated copy number evolution and clonal stasis in triple-negative breast cancer
Ruli Gao et al.
NATURE GENETICS (2016)
The tandem duplicator phenotype as a distinct genomic configuration in cancer
Francesca Menghi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann et al.
PLOS ONE (2016)
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
Yi-Rong Liu et al.
BREAST CANCER RESEARCH (2016)
Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants
Fresia Pareja et al.
NPJ BREAST CANCER (2016)
Are acinic cell carcinomas of the breast and salivary glands distinct diseases?
Salvatore Piscuoglio et al.
HISTOPATHOLOGY (2015)
Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer
Fergus J. Couch et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study
Elena Guerini-Rocco et al.
JOURNAL OF PATHOLOGY (2015)
Breast Cancer Genomics From Microarrays to Massively Parallel Sequencing: Paradigms and New Insights
Charlotte K. Y. Ng et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Clock-like mutational processes in human somatic cells
Ludmil B. Alexandrov et al.
NATURE GENETICS (2015)
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
Lucy R. Yates et al.
NATURE MEDICINE (2015)
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Douglas F. Easton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Breast Cancer Genomics From Microarrays to Massively Parallel Sequencing: Paradigms and New Insights
Charlotte K. Y. Ng et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: Triple-Negative Breast Cancer
Lisa A. Newman et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
Matthew D. Burstein et al.
CLINICAL CANCER RESEARCH (2015)
Metastatic breast carcinomas display genomic and transcriptomic heterogeneity
Britta Weigelt et al.
MODERN PATHOLOGY (2015)
Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models
Lorenzo Melchor et al.
JOURNAL OF PATHOLOGY (2014)
Clonal evolution in breast cancer revealed by single nucleus genome sequencing
Yong Wang et al.
NATURE (2014)
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adeno carcinomas of the salivary glands
Ilan Weinreb et al.
NATURE GENETICS (2014)
Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers
Johnathan A. Watkins et al.
BREAST CANCER RESEARCH (2014)
Genetic Susceptibility to Triple-Negative Breast Cancer
Kristen N. Stevens et al.
CANCER RESEARCH (2013)
Tackling the Diversity of Triple-Negative Breast Cancer
Nicholas C. Turner et al.
CLINICAL CANCER RESEARCH (2013)
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
Nasim Mavaddat et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Pan-cancer patterns of somatic copy number alteration
Travis I. Zack et al.
NATURE GENETICS (2013)
BRCA1 mutations and luminal-basal transformation
T. Ng et al.
ONCOGENE (2013)
Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation
F. Bai et al.
ONCOGENE (2013)
Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer
Anne-Renee Hartman et al.
CANCER (2012)
Mutational Processes Molding the Genomes of 21 Breast Cancers
Serena Nik-Zainal et al.
CELL (2012)
Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis
Felipe C. Geyer et al.
HISTOPATHOLOGY (2012)
Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers
Daniel Wetterskog et al.
JOURNAL OF PATHOLOGY (2012)
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Sohrab P. Shah et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Absolute quantification of somatic DNA alterations in human cancer
Scott L. Carter et al.
NATURE BIOTECHNOLOGY (2012)
Practical implications of gene-expression-based assays for breast oncologists
Aleix Prat et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
BRCA1 and BRCA2: different roles in a common pathway of genome protection
Rohini Roy et al.
NATURE REVIEWS CANCER (2012)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Breast Cancer 2 Gene expression profiling in breast cancer: classification, prognostication, and prediction
Jorge S. Reis-Filho et al.
LANCET (2011)
Deconstructing the molecular portraits of breast cancer
Aleix Prat et al.
MOLECULAR ONCOLOGY (2011)
BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells
Gemma Molyneux et al.
CELL STEM CELL (2010)
Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study
Katie M. O'Brien et al.
CLINICAL CANCER RESEARCH (2010)
A Marker of Homologous Recombination Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
Monika Graeser et al.
CLINICAL CANCER RESEARCH (2010)
DNA amplifications in breast cancer: genotypic-phenotypic correlations
Kai-Keen Shiu et al.
FUTURE ONCOLOGY (2010)
Breast cancer molecular profiling with single sample predictors: a retrospective analysis
Britta Weigelt et al.
LANCET ONCOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
N. Turner et al.
ONCOGENE (2010)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat et al.
BREAST CANCER RESEARCH (2010)
Molecular Evidence for Progression of Microglandular Adenosis (MGA) to Invasive Carcinoma
Sandra J. Shin et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Preclinical mouse models for BRCA1-associated breast cancer
R. M. Drost et al.
BRITISH JOURNAL OF CANCER (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
Elgene Lim et al.
NATURE MEDICINE (2009)
Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck
Marta Persson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: Further evidence to support the concept of low nuclear grade breast neoplasia family
Tarek M. A. Abdel-Fatah et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Triple negative tumours: a critical review
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2008)
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer
Rulla M. Tamimi et al.
BREAST CANCER RESEARCH (2008)
Opinion - Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis
John Stingl et al.
NATURE REVIEWS CANCER (2007)
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer
Xiaoling Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity
Anne Vincent-Salomon et al.
BREAST CANCER RESEARCH (2007)
Are triple-negative tumours and basal-like breast cancer synonymous?
Emad A. Rakha et al.
BREAST CANCER RESEARCH (2007)
Metaplastic breast carcinomas are basal-like tumours
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2006)
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
CA Livasy et al.
MODERN PATHOLOGY (2006)
Molecular classification and molecular forecasting of breast cancer: Ready for clinical application?
JD Brenton et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Will cancer stem cells provide new therapeutic targets?
F Behbod et al.
CARCINOGENESIS (2005)
Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ
EB Claus et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Hallmarks of 'BRCAness' in sporadic cancers
N Turner et al.
NATURE REVIEWS CANCER (2004)
Stem cells in normal breast development and breast cancer
G Dontu et al.
CELL PROLIFERATION (2003)
Salivary gland-like tumours of the breast: surgical and molecular pathology
M Pia-Foschini et al.
JOURNAL OF CLINICAL PATHOLOGY (2003)
Stem cells and breast cancer: A field in transit
M Smalley et al.
NATURE REVIEWS CANCER (2003)
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma
C Tognon et al.
CANCER CELL (2002)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
